Pink Sheet Podcast: Laid Off US FDA Staff Called Back, Vaccine Adcomm Cancelled, Lilly’s Manufacturing Push

Reporter and editors from the Pink Sheet and Medtech Insight discuss the impact of the FDA’s decision to call back many of the employees it laid off, the decision to cancel an upcoming FDA advisory committee meeting on flu vaccines, and Eli Lilly’s plans to increase domestic manufacturing.

Pink Sheet podcast
The VRBPAC meeting cancellation generated a lot of speculation about the FDA's reason for the move. • Source: Citeline/Shutterstock

More from Podcasts

More from Vaccines